Exicure Inc
XCUR
NASDAQ
Biotechnology
$1.25
USD
-0.06 (-4.58%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $8.29M
Volume 21.8K
Revenue
$0
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
$-9.78M
TTM
-66.9%
YoY
Operating Cash Flow
$-8.10M
TTM
-99.6%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | -100.0% | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 2.2 | 1.5 | 1.5 | 1.6 | 1.3 |
Other Operating Expenses | -6.0 | 0.0 | 0.0 | -6.0 | 0.0 |
Total Operating Expenses | -2.9 | 2.4 | 2.4 | -3.7 | 1.6 |
Operating Income | 2.9 | -2.4 | -2.4 | 3.7 | -1.6 |
EBITDA | -3.0 | -2.4 | -2.3 | -2.2 | -1.6 |
Other Income / Expense | 0.0 | -0.2 | -0.1 | -7.2 | -0.2 |
Total Other Income / Expense | 0.1 | -0.2 | -0.1 | -7.3 | -0.2 |
Income Before Income Taxes | 3.0 | -2.6 | -2.4 | -3.5 | -1.8 |
Income Taxes | 0.0 | 0.0 | 0.0 | -0.6 | 0.0 |
Net Income | 3.0 | -2.6 | -2.4 | -2.9 | -1.8 |
Consolidated Net Income / Loss | 3.0 | -2.6 | -2.4 | -2.9 | -1.8 |
Net Income Attributable to Common Shareholders | 3.0 | -2.6 | -2.4 | -2.9 | -1.8 |
Basic EPS | $0.49 | -$0.41 | -$0.39 | -$0.45 | -$0.29 |
Diluted EPS | $0.49 | -$0.41 | -$0.39 | -$0.46 | -$0.29 |
Basic Shares Outstanding | 6.2M | 6.3M | 6.3M | 6.4M | 6.4M |
Diluted Shares Outstanding | 6.2M | 6.3M | 6.3M | 6.4M | 6.4M |